Regarding the function of FEN1 in glioma progression, we hypothesized that a therapeutic effect can be optimized by targeting DNA replication via FEN1 inhibition and combining the effects of FEN1-mediated DNA damage signaling and clinical reagents that drive survival-related stress. The gene discussed is FEN1; the disease is central nervous system cancer.